17th May 2008 @ 2:16pm
 Subscribe | Instructions To Authors | Advertising/Supplements | Contact Us | Help

Volume 2, Supplement 1, March 2001


Angiotensin II receptor blockade: effects beyond blood pressure control

SUPPLEMENTPromise of prevention and reversal of target organ involvement in hypertension
Edward D Frohlich

POPULAR
TOPIC
SUPPLEMENTGene targeting studies of angiotensin II type 1 (AT1) receptors
Thomas M Coffman, Laurent P Audoly, Michael I Oliverio

POPULAR
TOPIC
SUPPLEMENTStructural requirements for signalling and regulation of AT1-receptors
László Hunyady, Zsuzsanna Gáborik, Georges Vauquelin, Kevin J Catt

POPULAR
TOPIC
SUPPLEMENTDistinctions between non-peptide angiotensin II AT1-receptor antagonists
Georges Vauquelin, Frederik LP Fierens, Ilse Verheijen, Patrick ML Vanderheyden

SUPPLEMENTRole of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan
Georges Vauquelin, Frederik LP Fierens, Zsuzsanna Gáborik, Tam Le Minh, Jean-Paul De Backer, László Hunyady, Patrick ML Vanderheyden

SUPPLEMENTCharacterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries
Hoa Ytterberg, Lars Edvinsson

SUPPLEMENTEvidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteries
Hoa Ytterberg, Lars Edvinsson

SUPPLEMENTAnalysis of responses to angiotensin II in the mouse
Trinity J Bivalacqua, Hunter C Champion, Albert L Hyman, Dennis B McNamara, Philip J Kadowitz

SUPPLEMENTDoes protein binding modulate the effect of angiotensin II receptor antagonists?
Marc P Maillard, Catherine Centeno, Åsa Frostell-Karlsson, Hans R Brunner, Michel Burnier

POPULAR
TOPIC
SUPPLEMENTInteraction among angiotensin II, nitric oxide and oxidative stress
Ming-Sheng Zhou, Ahmed Adam, Leopoldo Raij

SUPPLEMENTImprovement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?
Lodewijk J Wagenaar, Hendrik Buikema, Yigal M Pinto, Wiek H van Gilst

POPULAR
TOPIC
SUPPLEMENTFacilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells
Jawahar L Mehta, Dayuan Li

SUPPLEMENTPrevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
Vasilios Papademetriou, Philippe Mammillot, Robert Redman, Aldo Notargiacomo, Puneet Narayan, Raj Lakshman

SUPPLEMENTEffects of low-dose candesartan on the rate of re-endothelialisation following vascular wound healing
Prakash Koshy, Amanda Self, Philip J Kadowitz, Vivian A Fonseca, Dennis B McNamara

SUPPLEMENTCandesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
Daniel Casellas, Abderraouf Herizi, Annie Artuso, Albert Mimran, Bernard Jover

SUPPLEMENTPersistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
Karin Skov, Susie Mogensen, Michael J Mulvany

SUPPLEMENTAT1-receptors in the central nervous system
Andrew M Allen, Michelle E Giles, JooHyung Lee, Brian J Oldfield, Frederick AO Mendelsohn, Michael J McKinley

SUPPLEMENTThe role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia
Juan M Saavedra, Takeshi Ito, Yasuaki Nishimura

POPULAR
TOPIC
SUPPLEMENTRole of angiotensin in central regulation of sympathetic activity: effect of dietary sodium chloride
Gerald F DiBona

POPULAR
TOPIC
SUPPLEMENTThe renin-angiotensin system in obesity hypertension
Arya M Sharma, Stefan Engeli

SUPPLEMENTBlockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge
Andrew M Allen

SUPPLEMENTDevelopment of salt-sensitive hypertension in a sensory denervated model: the underlying mechanisms
Donna H Wang, Yan Huang

POPULAR
TOPIC
SUPPLEMENTCandesartan decreases the sympatho-adrenal and hormonal response to isolation stress
Ines Armando, Andrea Carranza, Yasuaki Nishimura, Marta Barontini, Takeshi Ito, Juan M Saavedra

SUPPLEMENTAT1-receptor blockade in experimental myocardial ischaemia/reperfusion
Rainer Schulz, Gerd Heusch

SUPPLEMENTReversal of cardiovascular remodelling with candesartan
Lindsay Brown, Andrew Fenning, Annie Shek, Darryl Burstow

POPULAR
TOPIC
SUPPLEMENTRegression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction
Emad Abro, Cory D Griffiths, Trefor O Morgan, Lea MD Delbridge

POPULAR
TOPIC
SUPPLEMENTCandesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy
Djamel Lebeche, Zhao Bin Kang, Roger Hajjar

POPULAR
TOPIC
SUPPLEMENTCardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor
Bodh I Jugdutt, Yi Xu, Mohammed Balghith, Vijayan Menon

SUPPLEMENTLessons on renal function from transgenic mice lacking different angiotensin II receptors
William J Arendshorst

SUPPLEMENTIntrarenal angiotensin II levels in normal and hypertensive states
L Gabriel Navar, Kenneth D Mitchell, Lisa M Harrison-Bernard, Hiroyuki Kobori, Akira Nishiyama

POPULAR
TOPIC
SUPPLEMENTThe renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
Norman K Hollenberg

SUPPLEMENTThe role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy
Matthew R Weir, Chiming Wei

SUPPLEMENTRelative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model
Karen A Griffin, Maria M Picken, George Bakris, Anil K Bidani

POPULAR
TOPIC
SUPPLEMENTThe effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion
Marc S Weinberg, Adam J Weinberg, Raymond Cord, Dion H Zappe

SUPPLEMENTAngiotensin II blockade causes acute renal failure in eNOS-deficient mice
Jürgen Schnermann, Yuning G Huang, Josie P Briggs

POPULAR
TOPIC
SUPPLEMENTComparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction
William F van Rodijnen, Ton A van Lambalgen, Marco E van Teijlingen, Geert-Jan Tangelder, Piet M ter Wee

SUPPLEMENTImprovements of renal lesions and function by angiotensin and endothelin receptor antagonism in nitric oxide-deficient rats
Jean-Jacques Boffa, Ying Lu, Jean-Claude Dussaule, Christos Chatziantoniou

SUPPLEMENTUse of angiotensin II receptor blockers alone and in combination with other drugs: a large clinical experience trial
Matthew R Weir, Rebecca Y Wang

POPULAR
TOPIC
SUPPLEMENTEffect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
Trefor Morgan